Syros Pharmaceuticals, Inc. · OTC:SYRS

Adage Capital Partners Gp, L.L.C.'s stake in Syros Pharmaceuticals, Inc. fell to 1.98% (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 12, 2025

Adage Capital Partners Gp, L.L.C.'s stake in Syros Pharmaceuticals, Inc. fell to 1.98%, 531,914 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G/A).

Stake
1.98%
Shares
531,914
Intent
Passive
What changed
Fell below 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Adage Capital Management, L.P.1.98%531,914
Adage Capital Partners GP, L.L.C.0%0
Robert Atchinson1.98%531,914
Phillip Gross1.98%531,914

Source

View original at SEC

Related